Path ID: DB00659_MESH_D000437_1

db00659-mesh-d000437-1

Concepts

Identifier Name Type
MESH:C043877 acamprosate Drug
InterPro:IPR001320 Ionotropic glutamate receptor GeneFamily
UniProt:Q9UBS5 Gamma-aminobutyric acid type B receptor subunit 1 Protein
InterPro:IPR006028 Gamma-aminobutyric acid A receptor/Glycine receptor alpha GeneFamily
GO:0045471 response to ethanol BiologicalProcess
GO:0098977 inhibitory chemical synaptic transmission BiologicalProcess
HP:0000739 Anxiety PhenotypicFeature
MESH:D000437 Alcoholism Disease

Relationships

NOTE: predicates are annotated in Biolink Model (v1.3.0)

Subject Predicate Object
Acamprosate NEGATIVELY REGULATES Gamma-Aminobutyric Acid Type B Receptor Subunit 1
Gamma-Aminobutyric Acid Type B Receptor Subunit 1 POSITIVELY REGULATES Gamma-Aminobutyric Acid A Receptor/Glycine Receptor Alpha
Gamma-Aminobutyric Acid A Receptor/Glycine Receptor Alpha POSITIVELY REGULATES Inhibitory Chemical Synaptic Transmission
Inhibitory Chemical Synaptic Transmission NEGATIVELY CORRELATED WITH Anxiety
Anxiety NEGATIVELY CORRELATED WITH Alcoholism
Acamprosate NEGATIVELY REGULATES Ionotropic Glutamate Receptor
Ionotropic Glutamate Receptor POSITIVELY REGULATES Response To Ethanol
Response To Ethanol CORRELATED WITH Alcoholism

Comment: Chronic alcohol exposure is believed to alter the normal balance between neuronal excitation and inhibition. Both in vitro and in vivo studies seem to suggest acamprosate may interact with glutamate and GABA neurotransmitter systems centrally, and has led to the hypothesis that acamprosate restores this balance (https://pubchem.ncbi.nlm.nih.gov/compound/71158#section=Mechanism-of-Action). The drug may not an effective therapy if be used alone (https://en.wikipedia.org/wiki/Acamprosate#Pharmacodynamics). Acamprosate may influence GABAA transmission via inhibition of presynaptic γ-aminobutyric acid type B (GABAB) receptors (https://pubmed.ncbi.nlm.nih.gov/9514305/).

Reference: